\
&
Contact us
\
&
Contact us
Published on | 1 year ago
Programmes Agro-Food, Environment MissionsThe third Water4all call on the topic “Water and Circular Economy” will be open on the 12th of September 2024.
The relevant subthemes of this call:
This call will be launched by the Water4all (Water Security for the Planet) partnership which is co-funded by the European Union within the frame of the Horizon Europe programme and includes a collaboration with VLAIO and FWO to allow more projects to be approved.
For more information, please access the dedicated pages below or contact your NCP.
https://www.vlaio.be/nl/nieuws/water4all-oproep-met-als-thema-water-en-circulaire-economie.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
AI Continent Advanced Digital Skills Deployment: Best use of technologies European Digital Innovation Hubs
The next round of Digital Europe calls has been published on the Funding & Tenders Portal of the European Commission. This next round comprises 14 call topics in total, covering the subdomains AI, data & cloud (see call topics here and here) Advanced Digital Skills Deployment European Digital Innovation Hubs The calls will o... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
